Skip to content

Testing the Effectiveness of Kanchnar Guggulu and Yoga in treating Subclinical Hypothyroidism

A randomized open labelled comparative Clinical study to evaluate the efficacy of Kanchnar Guggulu & Yoga Practice in the Management of Subclinical Hypothyroidism - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080040
Enrollment
60
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

None listed

Sponsors

Institute For Ayurved Studies Research Shri Krishna Ayush University Kurukshetra Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed cases of subclinical hypothyroidism with TSH ranging from 5.5 to 10 uIU/ml. 2.Patients of subclinical hypothyroidism, irrespective of sex, religion, profession, etc. 3.Patients with an age limit of 19-60 years. 4.Patients ofsubclinical hypothyroidism willing to take ayurvedic medicine and sign the consent form.

Exclusion criteria

Exclusion criteria: 1.Patients having ages below 19 years and more than 60 years. 2.Patient suffering from Primary hypothyroidism, and secondary hypothyroidism 3.Patients with hyperthyroidism, neoplasia, toxic goitre, and who have undergone any type of thyroid surgery 4.Patient taking a known drug to alter thyroid hormone level (Eg. Amiodarone) 5.Pregnant ladies and lactating mothers 6.Patients having any other major complicated diseases like Cardiac disease, renal failure, malignant disease, thyrotoxicosis & other systemic disorders 7.TPO (Thyroid Peroxidase) antibodies positive. 8.Taking OCP(Oral Contraceptive Pills) for longer duration. 9.Patient who take saindhav lavan or rock salt should not be included in trial, but after 3 monthes of introducing the iodinised salt IF TSH falls between 4- 10 uIU/ml than will be included in trial. 10.Patient not willing to take the trial.

Design outcomes

Primary

MeasureTime frame
To normalized the serum TSH level in significant range.Timepoint: Follow up for the objective parameters will be done on 30th day and 60th day.

Secondary

MeasureTime frame
Improvement in the lab values of serum cholesterol, serum triglyceride and serum Creatinine. 2.Quality of life of patient will be improved.Timepoint: Follow up for the objective parameters will be done on 30th day and 60th day.

Countries

India

Contacts

Public ContactDr Jogender

Institute For Ayurved Studies and Research, Faculty of Ayurved, Kurukshetra

jogendersaini.96@gmail.com9050126752

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026